Elite in Peripheral Neuropathy

Jordi Bruna

Barcelona, CT, ES 
Elite in Peripheral Neuropathy
Barcelona, CT, ES 
OverviewLocationsClinical Research

Overview

Jordi Bruna practices in Barcelona, Spain. Bruna is rated as an Elite expert by MediFind in the treatment of Peripheral Neuropathy. Their top areas of expertise are Peripheral Neuropathy, Neurotoxicity Syndromes, Glioma, and Astrocytoma.

Their clinical research consists of co-authoring 136 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 13 articles in the study of Peripheral Neuropathy.

Locations

Barcelona, CT, Spain
Other Locations
L'hospitalet De Llobregat, CT 08908, Spain
Bellaterra, CT, Spain
Cerdanyola Del Valles, CT 08193, Spain
Hospitalet De Ll, Spain

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase III Trial of Marizomib in Combination With Standard Temozolomide-based Radiochemotherapy Versus Standard Temozolomide-based Radiochemotherapy Alone in Patients With Newly Diagnosed Glioblastoma
A Phase III Trial of Marizomib in Combination With Standard Temozolomide-based Radiochemotherapy Versus Standard Temozolomide-based Radiochemotherapy Alone in Patients With Newly Diagnosed Glioblastoma
Enrollment Status: Completed
Publish Date: July 01, 2025
Intervention Type: Drug, Radiation
Study Drugs: Marizomib, Temozolomide
Study Phase: Phase 3
IDH Mutated 1p/19q Intact Lower Grade Glioma Following Resection: Wait Or Treat? IWOT - a Phase III Study
IDH Mutated 1p/19q Intact Lower Grade Glioma Following Resection: Wait Or Treat? IWOT - a Phase III Study
Enrollment Status: Terminated
Publish Date: February 01, 2022
Intervention Type: Radiation, Drug, Procedure
Study Drug: Temozolomide
Study Phase: Phase 3
View 1 Less Clinical Trial

135 Total Publications

Reaching the point-of-no-return: The cornerstone of glioblastoma treatment?
Reaching the point-of-no-return: The cornerstone of glioblastoma treatment?
Journal: Neuro-oncology advances
Published: September 22, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Bruna's expertise for a condition
ConditionClose
View All 7 Advanced Conditions
View All 13 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile